SCHEMBL15022089

SCHEMBL15022089

C[Si](C)(C)C#Cc1ccc(-c2n[nH]cc2-c2ccncc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 3/20 0.36
BRAF P15056 3/20 0.34
MAPK13 O15264 3/20 0.33
MAPK12 P53778 3/20 0.33
MAPK11 Q15759 3/20 0.33
MAPK14 Q16539 3/20 0.33
RAF1 P04049 1/20 0.33
MAPK8 P45983 1/20 0.33
MAPK9 P45984 1/20 0.33
MAPK10 P53779 1/20 0.33
KDM5A P29375 1/20 0.32
MKNK1 Q9BUB5 1/20 0.32
IMPDH2 P12268 2/20 0.32
MAPK1 P28482 1/20 0.32
HSD17B10 Q99714 1/20 0.32
KDM1A O60341 1/20 0.32
DYRK1A Q13627 1/20 0.32
CSNK1D P48730 1/20 0.31
CSNK1E P49674 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15022061 1.00 PDE10A (0.36) PDE10ABRAFMAPK13MAPK12MAPK11
SCHEMBL15022981 0.82 SLC2A1 (0.33) BRAFMAPK9MAPK10MAPK1
SCHEMBL5451902 0.80 IMPDH2 (0.44) BRAFMAPK13MAPK12MAPK11MAPK14
SCHEMBL15022254 0.80 HDAC8 (0.46) BRAFMAPK13MAPK12MAPK11MAPK14
SCHEMBL15023031 0.80 HDAC8 (0.46) BRAFMAPK13MAPK12MAPK11MAPK14
SCHEMBL30239600 0.78 MAPK14 (0.49) BRAFMAPK13MAPK12MAPK11MAPK14
SCHEMBL5256518 0.75 NOTUM (0.52) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL15022288 0.75 MAPK9 (0.50) PDE10AMAPK9MAPK10KDM1A
SCHEMBL17088191 0.74 ALDH1A1 (0.52) HSD17B10
SCHEMBL6078860 0.74 GCGR (0.49) MAPK13MAPK12MAPK11MAPK14RAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130158031-A1 ALKYNE-BRIDGED HETERO-AROMATICS AND USES THEREOF SU ZHOU JING HONG BIOTECH CO., LTD. (CN) 2013-06-20 US disclosed
US-20130158031-A1 ALKYNE-BRIDGED HETERO-AROMATICS AND USES THEREOF SU ZHOU JING HONG BIOTECH CO., LTD. (CN) 2013-06-20 US disclosed
US-20130158031-A1 ALKYNE-BRIDGED HETERO-AROMATICS AND USES THEREOF SU ZHOU JING HONG BIOTECH CO., LTD. (CN) 2013-06-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130158031-A1 ALKYNE-BRIDGED HETERO-AROMATICS AND USES THEREOF CHRNA10, ATXN10, SCN10A PDE10A 5/4885BRAF 2831/4885MAPK13 2559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.